General Biologicals Corporation (TPEX:4117)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
4.970
-2.780 (-35.87%)
Mar 10, 2026, 11:50 AM CST

General Biologicals Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
4711,2741,6151,6092,0823,231
Upgrade
Market Cap Growth
-56.94%-21.11%0.37%-22.70%-35.56%609.23%
Upgrade
Enterprise Value
2,7902,9571,8851,5282,1683,260
Upgrade
Last Close Price
7.7520.2626.1126.0133.6552.21
Upgrade
PE Ratio
----47.1651.98
Upgrade
PS Ratio
1.885.066.104.343.776.79
Upgrade
PB Ratio
3.004.453.252.322.834.70
Upgrade
P/TBV Ratio
4.545.533.692.563.135.19
Upgrade
P/FCF Ratio
----85.87137.56
Upgrade
P/OCF Ratio
--7.167.1553.4269.11
Upgrade
EV/Sales Ratio
11.1011.747.124.133.936.85
Upgrade
EV/EBITDA Ratio
----33.3851.37
Upgrade
EV/EBIT Ratio
----49.5175.18
Upgrade
EV/FCF Ratio
-4.34---89.43138.82
Upgrade
Debt / Equity Ratio
16.028.061.100.680.610.09
Upgrade
Debt / EBITDA Ratio
----5.710.92
Upgrade
Debt / FCF Ratio
----18.542.76
Upgrade
Net Debt / Equity Ratio
14.787.180.670.170.11-0.59
Upgrade
Net Debt / EBITDA Ratio
-12.68-10.54-2.20-5.191.24-6.44
Upgrade
Net Debt / FCF Ratio
-3.61-1.24-1.67-5.033.33-17.41
Upgrade
Asset Turnover
0.080.090.130.260.530.85
Upgrade
Inventory Turnover
2.723.432.002.013.694.86
Upgrade
Quick Ratio
0.900.780.294.215.406.24
Upgrade
Current Ratio
1.320.990.395.626.627.13
Upgrade
Return on Equity (ROE)
-87.72%-56.65%-33.60%-7.54%6.20%16.35%
Upgrade
Return on Assets (ROA)
-4.10%-4.54%-5.20%-1.81%2.61%4.86%
Upgrade
Return on Capital Employed (ROCE)
-6.80%-7.30%-11.30%-2.80%3.70%5.80%
Upgrade
Earnings Yield
-51.68%-17.33%-12.31%-3.31%2.12%1.92%
Upgrade
FCF Yield
-136.39%-130.36%-12.28%-1.46%1.17%0.73%
Upgrade
Buyback Yield / Dilution
---0.14%-13.44%-33.78%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.